Stock TEGC THRUST EN
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News THRUST EN OTC Bulletin Board

Equities

TEGC

US88602Q1094

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for THRUST EN
Apr. 16 CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI
Jan. 12 CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024
CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023
CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023
CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023
CI
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)
AQ
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)
AQ
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023
CI
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)
AQ
CNBX Pharmaceuticals Inc. Announces Board Resignations
CI
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022
CI
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc
CI
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022
CI
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt
CI
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
PR
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.
CI
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CNBX Stock
  4. TEGC Stock
  5. News THRUST EN